Ren Xu Institution-verified
Sourced from institutional research profiles (UAMS TRI or ARA).
Professor
faculty
COM | Radiation Oncology
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Ren Xu studies the roles of RORα in breast cancer development and progression. This research is supported by a grant from the NIH/National Cancer Institute, for which Xu serves as PI, totaling $62,602.
Xu is a Professor in the Department of Radiation Oncology at the University of Arkansas for Medical Sciences and an Innovation Scholar in the ARA Academy. Their research area is Cancer Research, and they maintain an active lab website.
ARA Academy 2025 Innovation Scholar
Dr. Xu is a newly appointed division director at the UAMS Cancer Institute. Previously a tenured professor of pharmacology at the University of Kentucky's Markey Cancer Center, his research focuses on microenvironmental cues and their modulation of breast cancer progression, with emphasis on identifying strategies to inhibit breast cancer metastasis and drug resistance. Several junior faculty he mentored have secured NIH R01 and foundation grants. His research has been continuously supported by multiple NCI R01 grants.
Policy Impact
Brings continuous NCI R01 grant funding and cancer research leadership to Arkansas, strengthening UAMS's capacity to compete for federal biomedical research dollars.
Growth Areas
['Population Health Innovations & Clinical Research']
Resources
Federal Grants 4 $961,192 total
Roles of mRNA transfer in cancer cell-platelet communication
The PLOD2/succinate axis in regulating cancer cell plasticity and stemness
Similar Researchers
Based on overlapping research topics